Search results
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 22 hours agoDive Insight: Merck currently sells two pneumococcal vaccines. One, dubbed Pneumovax 23, is for...
Merck Wins US Approval for Pneumonia Vaccine to Rival Pfizer’s
Bloomberg· 2 days agoMerck & Co. won US approval for a pneumococcal vaccine that threatens to unseat one of Pfizer Inc.’s...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
Reuters· 2 days ago, opens new tab filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false statements violated the Kansas Consumer Protection Act. "Pfizer ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 17 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 2 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 5 days agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 2 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Gateway - Quartz
Quartz· 9 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According to The People’s & ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 23 hours agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...